AlphaYouCM
Insider selling
Chad M Robins sold $14.9M of Adaptive Biotechnologies Corp (ADPT) stock
Chad M Robins, CEO and Chairman of Adaptive Biotechnologies Corp (ADPT), sold 600,000 shares of ADPT stock worth $14.9M, per an SEC Form 4 filed Aug 20, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 17, 2026, 3 days before it was made public.
ADPT has moved +12.5% since the trade date, from $24.77 to $27.86 (Sep 21, 2026 close).
- Traded
- Aug 17, 2026
- Disclosed
- Aug 20, 2026
- Filing delay
- 3 days
- Price since
- +12.5%
- Role
- CEO and Chairman
- Source
- SEC Form 4
More ADPT insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.